NEW YORK--(BUSINESS WIRE)--Medidata Solutions today announced that H. Lundbeck A/S has chosen to implement Medidata Rave 5.6 as its electronic data capture (EDC), management and reporting solution. An international pharmaceutical company focused on treatments for psychiatric and neurological disorders, Lundbeck plans to use Medidata Rave to manage several Phase II-IV trials in the coming months, with the goal of conducting 10 or more studies in Rave each year. Lundbeck’s first study in Medidata Rave 5.6 will launch in September 2007.
